Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine for palliative treatment of refractory dyspnea in advanced COPD
2014-004899-35Phase 3Completed
- Sponsor
- Maastricht University
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of morphine in chronic obstructive pulmonary disease (COPD), sponsored by Maastricht University. Primary endpoint: Change in disease-specific health-related quality of life. Started Jan 2015; status: completed.
02
Drugs
morphine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2014-004899-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004899-35.